| NDC Number | Brand Name | Generic Name | Manufacturer | Dosage Form | DEA Sch. | Marketing Start Date |
|---|---|---|---|---|---|---|
| 0024-0654 | Sarclisa | isatuximab | Sanofi-Aventis U.S. LLC | INJECTION, SOLUTION, CONCENTRATE | 2020-03-02 | |
| 0024-0656 | Sarclisa | isatuximab | Sanofi-Aventis U.S. LLC | INJECTION, SOLUTION, CONCENTRATE | 2020-03-02 | |
| 57894-502 | DARZALEX | Daratumumab | Janssen Biotech, Inc. | INJECTION, SOLUTION, CONCENTRATE | 2015-11-16 | |
| 57894-503 | Darzalex Faspro | daratumumab and hyaluronidase-fihj (human recombinant) | Janssen Biotech, Inc. | INJECTION | 2020-05-01 | |
| 57894-505 | Darzalex IV | Daratumumab | Janssen Biotech, Inc. | INJECTION, SOLUTION, CONCENTRATE | 2021-10-15 |
Loading full table content...